ATE449102T1 - Kristallines azithromycin-l-malat-monohydrat und pharmazeutische zusammensetzung, die dieses enthält - Google Patents

Kristallines azithromycin-l-malat-monohydrat und pharmazeutische zusammensetzung, die dieses enthält

Info

Publication number
ATE449102T1
ATE449102T1 AT06747495T AT06747495T ATE449102T1 AT E449102 T1 ATE449102 T1 AT E449102T1 AT 06747495 T AT06747495 T AT 06747495T AT 06747495 T AT06747495 T AT 06747495T AT E449102 T1 ATE449102 T1 AT E449102T1
Authority
AT
Austria
Prior art keywords
pharmaceutical composition
composition containing
containing same
crystalline azithromycin
malate monohydrate
Prior art date
Application number
AT06747495T
Other languages
English (en)
Inventor
Bo Sung Kwon
Eun Sook Kim
Hee Cheol Kim
Sangmin Yun
Myoung-Sil Ko
Tae Hun Song
Han Kyong Kim
Kwee Hyun Suh
Gwansun Lee
Original Assignee
Hanmi Pharm Ind Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hanmi Pharm Ind Co Ltd filed Critical Hanmi Pharm Ind Co Ltd
Application granted granted Critical
Publication of ATE449102T1 publication Critical patent/ATE449102T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H1/00—Processes for the preparation of sugar derivatives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Urology & Nephrology (AREA)
  • Pulmonology (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
AT06747495T 2005-06-08 2006-06-05 Kristallines azithromycin-l-malat-monohydrat und pharmazeutische zusammensetzung, die dieses enthält ATE449102T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR1020050048923A KR100666091B1 (ko) 2005-06-08 2005-06-08 아지스로마이신 ｌ-말산염 일수화물 및 이를 포함하는 약학조성물
PCT/KR2006/002157 WO2006132486A1 (en) 2005-06-08 2006-06-05 Crystalline azithromycin l-malate monohydrate and pharmaceutical composition containing same

Publications (1)

Publication Number Publication Date
ATE449102T1 true ATE449102T1 (de) 2009-12-15

Family

ID=37498652

Family Applications (1)

Application Number Title Priority Date Filing Date
AT06747495T ATE449102T1 (de) 2005-06-08 2006-06-05 Kristallines azithromycin-l-malat-monohydrat und pharmazeutische zusammensetzung, die dieses enthält

Country Status (13)

Country Link
US (1) US20090318375A1 (de)
EP (1) EP1910392B1 (de)
JP (1) JP2008543749A (de)
KR (1) KR100666091B1 (de)
CN (1) CN101193904A (de)
AT (1) ATE449102T1 (de)
AU (1) AU2006255914B2 (de)
CA (1) CA2610449A1 (de)
DE (1) DE602006010565D1 (de)
ES (1) ES2333610T3 (de)
IL (1) IL187639A0 (de)
RU (1) RU2348644C1 (de)
WO (1) WO2006132486A1 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8106111B2 (en) 2009-05-15 2012-01-31 Eastman Chemical Company Antimicrobial effect of cycloaliphatic diol antimicrobial agents in coating compositions
RU2512683C2 (ru) 2012-06-08 2014-04-10 Общество с ограниченной ответственностью "ВИК-здоровье животных" Антибактериальная инъекционная фармацевтическая композиция
CN115057814A (zh) * 2021-12-07 2022-09-16 山东新时代药业有限公司 一种米力农苹果酸盐晶体

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4474768A (en) * 1982-07-19 1984-10-02 Pfizer Inc. N-Methyl 11-aza-10-deoxo-10-dihydro-erytromycin A, intermediates therefor
DE60133083D1 (de) * 2000-01-04 2008-04-17 Teva Pharma Verfahren zur herstellung von azithromycin-dihydrat
ES2162764B1 (es) * 2000-05-17 2003-04-01 Ercros Ind Sa Forma polimorfica del dihidrato de azitromicina, y su procedimiento deobtencion.
CA2429639C (en) * 2000-11-27 2009-07-14 Biochemie S.A. Stable azithromycin monohydrate
KR100491183B1 (ko) * 2001-03-21 2005-05-25 한미약품 주식회사 아지트로마이신의 제조방법 및 이 방법에 사용되는9-데옥소-9에이-아자-9에이-호모에리트로마이신 에이의결정성 수화물
KR100431431B1 (ko) * 2001-04-25 2004-05-14 한미약품 주식회사 아지트로마이신 수화물의 1,2-프로필렌글리콜 내포화합물,그의 제조방법 및 그의 약학적 조성물
US6855813B2 (en) * 2002-07-19 2005-02-15 Alembic Limited Process for the preparation of azithromycin monohydrate
ES2220229B1 (es) 2003-05-29 2005-10-16 Quimica Sintetica, S.A. Sales de adicion de azitromicina y acido citrico y procedimiento para su obtencion.
GB2395482A (en) * 2003-07-03 2004-05-26 Jubilant Organosys Ltd Process for preparing non-hygroscopic azithromycin dihydrate

Also Published As

Publication number Publication date
JP2008543749A (ja) 2008-12-04
CA2610449A1 (en) 2006-12-14
ES2333610T3 (es) 2010-02-24
CN101193904A (zh) 2008-06-04
IL187639A0 (en) 2008-03-20
WO2006132486A1 (en) 2006-12-14
KR20060128066A (ko) 2006-12-14
EP1910392A4 (de) 2008-10-29
EP1910392B1 (de) 2009-11-18
DE602006010565D1 (de) 2009-12-31
EP1910392A1 (de) 2008-04-16
RU2348644C1 (ru) 2009-03-10
KR100666091B1 (ko) 2007-01-10
US20090318375A1 (en) 2009-12-24
AU2006255914A1 (en) 2006-12-14
AU2006255914B2 (en) 2009-09-03

Similar Documents

Publication Publication Date Title
NL301039I1 (nl) Fostamatinib of een farmaceutisch aanvaardbaar zout van fostamatinib, of een hydraat, solvaat of N-oxide van fostamatinib of het farmaceutisch aanvaardbare zout van fostamatinib, in het bijzonder dinatriumfostamatinib eventueel in de vorm van een hydraat
NO20092611L (no) Krystallinsk faststoff Rasagilin base
EP1962838A4 (de) Farnesoid-x-rezeptor-agonisten
IL182869A0 (en) Non-hygroscopic and powdery amorphous pimecrolimus
WO2007125547A3 (en) Novel process for statins and its pharmaceutically acceptable salts thereof
TW200734344A (en) Antibacterial agents
CL2007002100A1 (es) Compuestos derivados biciclicos que contienen nitrogeno, sus sales, solvatos y n-oxidos; composicion farmaceutica; y uso para el tratamiento de infecciones bacterianas.
TW200720232A (en) Crystalline solid forms of tigecycline and methods of preparing same
EA200801428A1 (ru) Производные пиридиазинона для лечения опухолей
TW200744588A (en) Pharmaceutical composition for external use
WO2006120563A3 (en) Antibacterial agents
TW200740776A (en) N-phenylbenzotriazolyl c-kit inhibitors
MY140739A (en) 2, 6-quinolinyl derivatives, processes for preparing them and their uses
EP1917542A4 (de) Verfahren zur tomographischen inversion durch matrixtransformation
SG150518A1 (en) Macrolides and methods for producing same
NO20053687D0 (no) Crystallisation Process.
ATE490958T1 (de) Als agonisten für den nikotinischen acetylcholinrezeptor geeignete azabicycloalkanderivate
FR2903983B1 (fr) Procede de fabrication de diesters.
MX274842B (es) Procedimiento para la produccion de sales de (4,5-dihidroisoxazol- 3-il)tiocarboxamidina.
MX2009004030A (es) Articulos antimicrobianos y metodos de fabricacion.
SG170054A1 (en) Heteroaryl pyrrolidinyl and piperidinyl ketone derivatives
DE602004012269D1 (de) Quervernetzte glycopeptid-cephalosporin-antibiotika
DE602004024393D1 (de) Quervernetzte glycopeptid-cephalosporin-antibiotika
SG148168A1 (en) Genetically modified microorganism and process for production of macrolide compound using the microorganism
GB2456096A (en) Crystalline form of benzothiophene compound and process for preparation thereof

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties